ORYZON presents preliminary data from ongoing Phase Ib FRIDA trial with iadademstat plus gilteritinib in relapsed/refractory FLT3-mut AML patients at EHA-2024

by Oryzon Genomics

Data from the first two cohorts demonstrated that combination of iadademstat plus gilteritinib was safe and showed strong antileukemic activity

Read more

The Spanish Medicines Agency authorizes UGRSKIN, the artificial skin created by ibs.GRANADA scientists, as a medicine for consolidated use in hospitals

by Instituto de Investigación Biosanitaria - Ibs Granada

Considered an advanced therapy medicine, it was designed by the Tissue Engineering Group of the Department of Histology of the Faculty of Medicine of the UGR and the Biosanitary Research Institute ibs...

Read more

Aprobado en Estados Unidos un nuevo fármaco para tratar las fases iniciales del Alzheimer

by Fundación Pasqual Maragall

Este nuevo fármaco recibe luz verde para el tratamiento de personas con síntomas tempranos del Alzheimer.

Read more

ORYZON reports financial results and corporate update for half-year ending June 30, 2024

by Oryzon Genomics

R&D investments of € 4.6 million were made, of which € 4.2 million in development and € 0.4 million in research. Following the completion of the PORTICO clinical trial, the R&D investment intens...

Read more

La EMA recomienda ahora aprobar el polémico fármaco lecanemab contra el alzhéimer

by Agencia Sinc

La Agencia Europea del Medicamento ha cambiado de opinión y respalda la utilización de este medicamento para el tratamiento del alzhéimer en fases iniciales. Aunque reduce un 27 % el deterioro cogn...

Read more

Lainco presenta Nasucure: hidratación y regeneración para tu mucosa nasal

by Lainco

Nasucure es una pomada nasal hidratante y regeneradora, que está diseñada para aliviar la sequedad y la congestión nasal de manera rápida, efectiva y segura, brindando el bienestar que realmente m...

Read more

Identifying the Factors That Accelerate Full FDA Approval of Oncology Drugs

by Hospital de la Santa Creu i Sant Pau

A study led by Dr. Ariadna Tibau, researcher at the Sant Pau Research Institute (IR Sant Pau) and oncologist at Hospital de Sant Pau, was recently published in the journal JAMA Network Open. The artic...

Read more

New Guide for Medical Devices in Spain | Now available

by Asphalion

A new guide has been published by the Spanish Agency of Medicines and Medical Devices (AEMPS), providing a consolidated reference for regulatory requirements applicable to the marketing of medical dev...

Read more

aptaTargets transfiere ApTOLL a Merck

by AptaTargets

ApTOLL completó un estudio clínico de Fase 1b/2 para el ictus isquémico agudo con resultados positivos. Merck asumirá el desarrollo clínico y la comercialización del fármaco.

Read more

Tufts Center Study Shows Significant Time Savings in Delivering Therapies to Patients with Thermo Fisher Scientific’s Accelerator™ Drug Development 360° CDMO and CRO Solutions

by Thermo Fisher Scientific

Time matters for patients in need, and new research shows integrated services can reduce Phase I-III study times by up to nearly three years, generating strong ROI for biotech and biopharma customers ...

Read more

Leriglitazone Marketing Authorization Application submitted for treatment of cerebral adrenoleukodystrophy has been validated by European Medicines Agency

by Ysios Capital

Minoryx Therapeutics today announce that the Marketing Authorization Application (MAA) for Minoryx’s lead candidate leriglitazone (NEZGLYAL®) has been submitted to the European Medicines Agency (EM...

Read more

The European Commission authorizes the marketing of donanemab for the treatment of early-stage Alzheimer’s

by Fundación Pasqual Maragall

Following the EMA's positive opinion in July, the European Commission has now authorized the drug for marketing.

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream